BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10609885)

  • 21. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.
    Zhang Y; Dhandayuthapani S; Deretic V
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13212-6. PubMed ID: 8917570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of OxyS of Mycobacterium tuberculosis in oxidative stress: overexpression confers increased sensitivity to organic hydroperoxides.
    Domenech P; Honoré N; Heym B; Cole ST
    Microbes Infect; 2001 Jul; 3(9):713-21. PubMed ID: 11489419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.
    Heym B; Zhang Y; Poulet S; Young D; Cole ST
    J Bacteriol; 1993 Jul; 175(13):4255-9. PubMed ID: 8320241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress.
    Koshkin A; Zhou XT; Kraus CN; Brenner JM; Bandyopadhyay P; Kuntz ID; Barry CE; Ortiz de Montellano PR
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2424-30. PubMed ID: 15215090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.
    Doustdar F; Khosravi AD; Farnia P; Masjedi MR; Velayati AA
    Microb Drug Resist; 2008 Dec; 14(4):273-9. PubMed ID: 19090721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis.
    Silva MS; Senna SG; Ribeiro MO; Valim AR; Telles MA; Kritski A; Morlock GP; Cooksey RC; Zaha A; Rossetti ML
    J Clin Microbiol; 2003 Sep; 41(9):4471-4. PubMed ID: 12958298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxiredoxin systems in mycobacteria.
    Jaeger T
    Subcell Biochem; 2007; 44():207-17. PubMed ID: 18084895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro.
    Manca C; Paul S; Barry CE; Freedman VH; Kaplan G
    Infect Immun; 1999 Jan; 67(1):74-9. PubMed ID: 9864198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.
    van Doorn HR; Kuijper EJ; van der Ende A; Welten AG; van Soolingen D; de Haas PE; Dankert J
    J Clin Microbiol; 2001 Apr; 39(4):1591-4. PubMed ID: 11283093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG.
    Abate G; Hoffner SE; Thomsen VO; Miörner H
    Eur J Clin Microbiol Infect Dis; 2001 May; 20(5):329-33. PubMed ID: 11453593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
    Lee AS; Teo AS; Wong SY
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum.
    Pagán-Ramos E; Song J; McFalone M; Mudd MH; Deretic V
    J Bacteriol; 1998 Sep; 180(18):4856-64. PubMed ID: 9733688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production.
    Wei CJ; Lei B; Musser JM; Tu SC
    Antimicrob Agents Chemother; 2003 Feb; 47(2):670-5. PubMed ID: 12543676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona.
    Coll P; Aragón LM; Alcaide F; Espasa M; Garrigó M; González J; Manterola JM; Orús P; Salvadó M
    Microb Drug Resist; 2005; 11(2):107-14. PubMed ID: 15910223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
    Zhang Y; Heym B; Allen B; Young D; Cole S
    Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of katG gene in resistant Mycobacterium tuberculosis.
    Jaber M; Rattan A; Kumar R
    J Clin Pathol; 1996 Nov; 49(11):945-7. PubMed ID: 8944618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid.
    Deretic V; Pagán-Ramos E; Zhang Y; Dhandayuthapani S; Via LE
    Nat Biotechnol; 1996 Nov; 14(11):1557-61. PubMed ID: 9634820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.